AIRAStrat

Risk Stratification in Prostate Cancer

AIRAStrat
Screenshot of AIRAStrat web app for prediction of tumor upgrades, recurrence, metastasis, and metastasis-free survival.
Risk Stratification in Prostate Cancer

Product Overview



Multimodality-trained AI solutions for risk stratification at biopsy and post-radical prostatectomy. Endpoint prediction of tumor upgrades, biochemical recurrence, metastasis, and metastasis-free survival.

Disclaimer: Unless otherwise stated, all products are “Research Use Only”; not for use in diagnostic procedures.
Why AIRAStrat
 
Trained using multimodality data with clinical outcomes as ground truth
Predicts the course of disease with up to 0.91 AUC
Improved performance compared to conventional methods such as genomic classifiers.
Applications of AIRAStrat in Prostate Cancer Care Pathway
 
At Diagnosis: Improved ability to classify patients for active surveillance and minimize unnecessary treatments
Post Surgery: Optimal therapy selection to minimize treatment-related complications
AIRAStrat sample report with metastatic risk regions highlighted on a WSI with a 15-year metastasis probability graph.
 
Metastatic Risk Heatmap

The AIRAStrat heatmap overlay for prostate biopsy images highlights regions of high, intermediate, and low metastatic risk, providing a model explanation to support early identification of metastatic progression. By integrating clinical data with histopathology, AIRAStrat enhances risk stratification, empowering clinicians with data-driven insights for informed decision-making.

Metastasis Prediction

Generate a time-dependent probability graph of metastatic events. The 15-year projection integrates clinical, genomics, and pathology data and provides insights into metastasis risks to support long-term prognosis and personalized prostate cancer management.

Technical Specifications

Scanner Agnostic

Compatible with multiple image formats and scanners
Analysis Mode

Auto, Manual
Specimen

Core Needle Biopsy, Radical Prostatectomy
Stain

H&E
Deployment

Cloud, On-Premise
Export Results

CSV, PDF
Learn more about how AIRAStrat can benefit your patients, schedule a free demo now!

FAQs


AIRAStrat utilizes various data sources to train, including pathology images, genomic data, and clinical parameters such as patient age, PSA levels, and family history. With the multimodality approach, AIRAStrat offers a comprehensive understanding of each patient's case.
Yes, AIRAStrat complies with HL7 metadata standards and integrates into existing digital image management systems.
AIRAStrat is designed with security and privacy in mind. It adheres to industry standards for data protection and encrypts patient information.
No, AIRAStrat is an assistive tool to empower pathologists. It automates tedious tasks, allowing them to focus on complex cases and provide better patient care.
Yes, AIRAStrat is designed to be user-friendly for pathologists with varying experience with AI tools. We also offer training resources and support to ensure a smooth onboarding process.
Quick Links
Get Updates
© Copyright 2025. AIRA MATRIX. All Rights Reserved.
Request A Demo
Name *
First Name
 
Last Name
Organization *
Company Name
Email *
example@example.com
Phone Please enter a valid phone number
Region *
Your location
Which of our products are you interested in
  Custom AI Development
  Digital Pathology as a Service (DPaaS)
  Image Management System (AIRADHI)
  Predictive Toxicology (PredTox)
  Prostate Diagnosis (AIRAProstate)
  Prostate Stratification (AIRAStrat)
  Prostate Prediction (AIRAPredict)
  Quality Control (AIRAQc)
  Safety Assessment (AIRATox)